162 related articles for article (PubMed ID: 18051783)
1. [In order to perform clinical trials efficiently in Japan--important issues regarding monitoring by sponsors].
Kaichi S; Oda T; Goto K; Sato K
Nihon Kokyuki Gakkai Zasshi; 2007 Nov; 45(11):829-35. PubMed ID: 18051783
[TBL] [Abstract][Full Text] [Related]
2. [In order to perform clinical trials efficiently in Japan--important issues in medical institutions raised by the GCP on-site review].
Akiyama T; Furuta M; Yamada H
Nihon Kokyuki Gakkai Zasshi; 2006 Aug; 44(8):541-9. PubMed ID: 16972610
[TBL] [Abstract][Full Text] [Related]
3. [Performing clinical trials efficiently in Japan--independent clinical trials and GCP].
Kanai M; Suzuki-Nishimura T
Nihon Kokyuki Gakkai Zasshi; 2007 Jun; 45(6):449-54. PubMed ID: 17644939
[TBL] [Abstract][Full Text] [Related]
4. [Development of anti-cancer drugs under new renewed GCP--from the viewpoint of drug development company developer].
Ueno T; Kobayashi T; Inoue K; Yanagi Y; Yamada Y
Gan To Kagaku Ryoho; 1998 Apr; 25(5):663-70. PubMed ID: 9571963
[TBL] [Abstract][Full Text] [Related]
5. [Implementation of new Japanese GCP and the quality of clinical trials--from the standpoint of the pharmaceutical industry].
Ebi O
Gan To Kagaku Ryoho; 1997 Oct; 24(13):1883-91. PubMed ID: 9350232
[TBL] [Abstract][Full Text] [Related]
6. [Experience as a model hospital for new good clinical practice (GCP) regulations].
Tanaka S
Gan To Kagaku Ryoho; 1998 Aug; 25(10):1467-73. PubMed ID: 9725036
[TBL] [Abstract][Full Text] [Related]
7. [Introduction of new GCP (good clinical practice)].
Miyake S
Gan To Kagaku Ryoho; 1998 Apr; 25(5):645-9. PubMed ID: 9571961
[TBL] [Abstract][Full Text] [Related]
8. [Recording and reporting adverse reactions in clinical trials. New legal provisions according to the 12th Law Amending the German Drug Law (AMG) and the Ordinance on GCP (GCP-V)].
Eckhardt K; Cremer-Schaeffer P; König J; Paeschke N
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Feb; 48(2):173-80. PubMed ID: 15726458
[TBL] [Abstract][Full Text] [Related]
9. GCP data quality for early clinical development.
Rock EP; Molloy VJ; Humphrey JS
Clin Cancer Res; 2010 Mar; 16(6):1756-63. PubMed ID: 20215550
[TBL] [Abstract][Full Text] [Related]
10. [How to establish GCP-units in Denmark?].
Krogsgaard K; Andreasen PB
Ugeskr Laeger; 2003 Apr; 165(16):1665-7. PubMed ID: 12756825
[TBL] [Abstract][Full Text] [Related]
11. Ethical considerations in clinical trials: a critique of the ICH-GCP guideline.
Kaur S; Choy CY
Dev World Bioeth; 2014 Apr; 14(1):20-8. PubMed ID: 23170779
[TBL] [Abstract][Full Text] [Related]
12. [ICH-GCP Guideline: quality assurance of clinical trials. Status and perspectives].
Englev E; Petersen KP
Ugeskr Laeger; 2003 Apr; 165(16):1659-62. PubMed ID: 12756823
[TBL] [Abstract][Full Text] [Related]
13. [Doctor-initiated clinical trials and the revised pharmaceutical affairs law].
Takano T; Saijo N
Gan To Kagaku Ryoho; 2003 Oct; 30(10):1391-7. PubMed ID: 14584270
[TBL] [Abstract][Full Text] [Related]
14. [Impact of the last 15 years: from PMDEC to PMDA --looking back at the first stage of the PMDEC].
Morimoto K; Fujiwara Y; Kawahara A
Yakushigaku Zasshi; 2011; 46(1):38-50. PubMed ID: 22164689
[TBL] [Abstract][Full Text] [Related]
15. [The guideline for clinical trials proposed by Japan Society for Cancer Therapy (JSCT)].
Kurihara M
Gan To Kagaku Ryoho; 1996 Jan; 23(2):156-65. PubMed ID: 8611043
[TBL] [Abstract][Full Text] [Related]
16. [Development of an anticancer drug in Japan based on a new clinical trial system].
Nakashima H; Nakano S
Gan To Kagaku Ryoho; 1998 Feb; 25(3):287-94. PubMed ID: 9492818
[TBL] [Abstract][Full Text] [Related]
17. Regulatory frameworks for cell therapy products in Japan.
Yanagi K; Fukuda E; Jotatsu Y; Shikano M; Miyake S
J Artif Organs; 2012 Dec; 15(4):325-30. PubMed ID: 22864765
[TBL] [Abstract][Full Text] [Related]
18. [Public GCP unit--experiences from the Aarhus University Hospital].
Jørgensen A; Rønnow IL; Nexø E
Ugeskr Laeger; 2003 Apr; 165(16):1667-9. PubMed ID: 12756826
[TBL] [Abstract][Full Text] [Related]
19. [The GCP directive--consequences for clinical drug research].
Gluud CN
Ugeskr Laeger; 2003 Apr; 165(16):1662-4. PubMed ID: 12756824
[TBL] [Abstract][Full Text] [Related]
20. Clinical trials and the new good clinical practice guideline in Japan. An economic perspective.
Ono S; Kodama Y
Pharmacoeconomics; 2000 Aug; 18(2):125-41. PubMed ID: 11067647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
